Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia

Detalles Bibliográficos
Autores principales: Delgado, Julio, Caballero-Baños, Miguel, Ortiz-Maldonado, Valentín, Castellà, Maria, Magnano, Laura, Juan, Manel, Urbano-Ispizua, Álvaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746038/
https://www.ncbi.nlm.nih.gov/pubmed/31723815
http://dx.doi.org/10.1097/HS9.0000000000000174
_version_ 1783451645243293696
author Delgado, Julio
Caballero-Baños, Miguel
Ortiz-Maldonado, Valentín
Castellà, Maria
Magnano, Laura
Juan, Manel
Urbano-Ispizua, Álvaro
author_facet Delgado, Julio
Caballero-Baños, Miguel
Ortiz-Maldonado, Valentín
Castellà, Maria
Magnano, Laura
Juan, Manel
Urbano-Ispizua, Álvaro
author_sort Delgado, Julio
collection PubMed
description
format Online
Article
Text
id pubmed-6746038
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-67460382019-11-13 Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia Delgado, Julio Caballero-Baños, Miguel Ortiz-Maldonado, Valentín Castellà, Maria Magnano, Laura Juan, Manel Urbano-Ispizua, Álvaro Hemasphere Case Report Wolters Kluwer Health 2019-02-08 /pmc/articles/PMC6746038/ /pubmed/31723815 http://dx.doi.org/10.1097/HS9.0000000000000174 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Case Report
Delgado, Julio
Caballero-Baños, Miguel
Ortiz-Maldonado, Valentín
Castellà, Maria
Magnano, Laura
Juan, Manel
Urbano-Ispizua, Álvaro
Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
title Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
title_full Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
title_fullStr Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
title_full_unstemmed Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
title_short Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
title_sort chimeric antigen receptor t cells targeting cd19 and ibrutinib for chronic lymphocytic leukemia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746038/
https://www.ncbi.nlm.nih.gov/pubmed/31723815
http://dx.doi.org/10.1097/HS9.0000000000000174
work_keys_str_mv AT delgadojulio chimericantigenreceptortcellstargetingcd19andibrutinibforchroniclymphocyticleukemia
AT caballerobanosmiguel chimericantigenreceptortcellstargetingcd19andibrutinibforchroniclymphocyticleukemia
AT ortizmaldonadovalentin chimericantigenreceptortcellstargetingcd19andibrutinibforchroniclymphocyticleukemia
AT castellamaria chimericantigenreceptortcellstargetingcd19andibrutinibforchroniclymphocyticleukemia
AT magnanolaura chimericantigenreceptortcellstargetingcd19andibrutinibforchroniclymphocyticleukemia
AT juanmanel chimericantigenreceptortcellstargetingcd19andibrutinibforchroniclymphocyticleukemia
AT urbanoispizuaalvaro chimericantigenreceptortcellstargetingcd19andibrutinibforchroniclymphocyticleukemia

Ejemplares similares